Drug Shortage Report for BIO-LETROZOLE

Last updated on 2021-10-21 History
Report ID 18781
Drug Identification Number 02392496
Brand name BIO-LETROZOLE
Common or Proper name LETROZOLE
Company Name BIOMED PHARMA
Market Status MARKETED
Active Ingredient(s) LETROZOLE
Strength(s) 2.5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code L02BG
ATC description HORMONE ANTAGONISTS AND RELATED AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2019-06-01
Actual start date 2019-06-01
Estimated end date
Actual end date 2021-10-20
Shortage status Resolved
Updated date 2021-10-21
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 9450 BOUL. LANGELIER
MONTREAL, QUEBEC
CANADA H1P 3H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-10-21 English Compare
v11 2021-10-20 French Compare
v10 2021-10-20 English Compare
v9 2019-07-17 French Compare
v8 2019-07-17 English Compare
v7 2019-07-17 French Compare
v6 2019-07-17 English Compare
v5 2017-09-20 French Compare
v4 2017-09-20 English Compare
v3 2017-09-20 French Compare
v2 2017-08-11 French Compare
v1 2017-08-11 English Compare

Showing 1 to 12 of 12